Trade Zynerba Pharmaceuticals, Inc. - ZYNE CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024151% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001929% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.25 |
| Open | 1.25 |
| 1-Year Change | 73.61% |
| Day's Range | 1.25 - 1.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Oct 10, 2023 | 1.29 | 0.05 | 4.03% | 1.24 | 1.31 | 1.24 |
| Oct 9, 2023 | 1.25 | 0.04 | 3.31% | 1.21 | 1.26 | 1.21 |
| Oct 6, 2023 | 1.25 | 0.05 | 4.17% | 1.20 | 1.25 | 1.20 |
| Oct 5, 2023 | 1.24 | 0.06 | 5.08% | 1.18 | 1.24 | 1.18 |
| Oct 4, 2023 | 1.19 | -0.04 | -3.25% | 1.23 | 1.24 | 1.16 |
| Oct 3, 2023 | 1.24 | 0.00 | 0.00% | 1.24 | 1.24 | 1.21 |
| Oct 2, 2023 | 1.24 | -0.01 | -0.80% | 1.25 | 1.25 | 1.23 |
| Sep 29, 2023 | 1.25 | -0.01 | -0.79% | 1.26 | 1.26 | 1.24 |
| Sep 28, 2023 | 1.26 | 0.01 | 0.80% | 1.25 | 1.26 | 1.25 |
| Sep 27, 2023 | 1.25 | 0.01 | 0.81% | 1.24 | 1.28 | 1.24 |
| Sep 26, 2023 | 1.26 | -0.04 | -3.08% | 1.30 | 1.31 | 1.25 |
| Sep 25, 2023 | 1.30 | 0.00 | 0.00% | 1.30 | 1.30 | 1.30 |
| Sep 22, 2023 | 1.31 | 0.01 | 0.77% | 1.30 | 1.32 | 1.30 |
| Sep 21, 2023 | 1.30 | -0.01 | -0.76% | 1.31 | 1.33 | 1.29 |
| Sep 20, 2023 | 1.33 | 0.03 | 2.31% | 1.30 | 1.34 | 1.30 |
| Sep 19, 2023 | 1.31 | 0.00 | 0.00% | 1.31 | 1.33 | 1.31 |
| Sep 18, 2023 | 1.31 | -0.02 | -1.50% | 1.33 | 1.34 | 1.31 |
| Sep 15, 2023 | 1.36 | 0.05 | 3.82% | 1.31 | 1.37 | 1.31 |
| Sep 14, 2023 | 1.32 | 0.02 | 1.54% | 1.30 | 1.32 | 1.30 |
| Sep 13, 2023 | 1.30 | 0.00 | 0.00% | 1.30 | 1.33 | 1.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It improves the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome, autism spectrum disorder, 22q11.2 deletion syndrome, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and epileptic encephalopathies. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.| Industry: | Biotechnology & Medical Research (NEC) |
80 W. Lancaster Avenue
Suite 300
DEVON
PENNSYLVANIA 19333
US
News
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024
US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com